Profile
Mr. Jamal El-Mosleh is a Chief Executive Officer at Elicera Therapeutics AB. Mr. El-Mosleh was previously employed as a Chief Executive Officer by Annexin Pharmaceuticals AB and a Chief Executive Officer & IR Contact by Immunicum AB. He also served on the board at Elypta AB. He received his graduate degree from Chalmers University of Technology and a graduate degree from Chalmers School of Entrepreneurship.
Jamal El-Mosleh active positions
| Companies | Position | Start |
|---|---|---|
| ELICERA THERAPEUTICS AB | Chief Executive Officer | 2019-12-31 |
Former positions of Jamal El-Mosleh
| Companies | Position | End |
|---|---|---|
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Develops and operates software platform for artificial intelligence algorithms trained by our clinical database | Director/Board Member | 2019-12-31 |
| ANNEXIN PHARMACEUTICALS AB | Chief Executive Officer | 2018-12-31 |
| MENDUS AB | Chief Executive Officer | 2016-09-30 |
Training of Jamal El-Mosleh
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Chalmers University of Technology
Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mendus AB
Mendus AB BiotechnologyHealth Technology Develops immunotherapies for therapeutic treatment of cancer | Health Technology |
Chalmers School of Entrepreneurship
Chalmers School of Entrepreneurship Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Annexin Pharmaceuticals AB
Annexin Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures drugs for cardiovascular diseases | Health Technology |
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Develops and operates software platform for artificial intelligence algorithms trained by our clinical database | Technology Services |
Elicera Therapeutics AB
Elicera Therapeutics AB BiotechnologyHealth Technology Develops and trades cell and gene therapies in immune-oncology | Health Technology |
- Stock Market
- Insiders
- Jamal El-Mosleh
















